Skip to main content

Creation of an Experience Journey Map and Action Framework to deliver integration and efficiency within chronic kidney disease service provision with Health Innovation Manchester

A Collaborative Working project between Boehringer Ingelheim Limited (BIL) and the Greater Manchester Health and Care System through Health Innovation Manchester (HInM) to deliver integration and efficiency within chronic kidney disease (CKD) service provision, through the creation of an experience journey map and action framework.

Health Innovation Manchester work with innovators to discover, develop, and deploy new solutions that improve the health and wellbeing of Greater Manchester’s 2.8 million citizens. 

The key objectives of this project are;

  • To identify opportunities to improve the healthcare journey that impacts access to care, patient experience, and measurable health outcomes.

  • To visualise an actionable service blueprint uncovering the burden of CKD in the GM region and to understand how current resources are utilised including the pathways and their impact on patients, caregivers, and healthcare professionals, informing future pieces of work at a patient, system, and national level. 

  • To continue to form collaborative and creative engagement with diverse stakeholders from across an integrated healthcare system to transform care pathways.

Greater Manchester Health and Care System are committed to improve their understanding of the challenges related to the delivery of care for citizens with chronic kidney disease, and collectively address changes needed for effective management across the health and care system. They plan to incorporate these findings into their operational strategies to unify healthcare services making this collaboration a model for advanced integration.

This project aims to mobilise resources for a period of 9 months from October 2023 until end of May 2024

Boehringer Ingelheim Limited is pleased to collaborate with Health Innovation Manchester (and affiliated partners) to design and deliver this Collaborative Working Project.

And this is what we proposed as the closure to the programme:

Completed Outcomes

Over a nine-month period, Health Innovation Manchester, Boehringer Ingelheim, and The Care Lab collaborated on the Local Carepath Optimisation (LCO) project. This iterative, participatory, and insights-driven approach aimed to transform healthcare systems by addressing structural challenges and systemic inequalities. Central to this methodology was the engagement of patients, carers, and healthcare professionals in a co-creation process to identify current gaps in care and define opportunities for improvement. This collaborative effort within the Greater Manchester Health System resulted in a locality blueprint designed to enhance integration, experience, and outcomes in care delivery.

Stakeholder co-creation identified nine opportunity areas to transform chronic kidney disease (CKD) care pathways. These areas suggest both innovative connections between existing services and the creation of new services and strategies to improve CKD care in Greater Manchester. Additionally, a transversal opportunity emerged, emphasizing coordinated care delivery, effective interdisciplinary communication, cross-system training programs, and platforms for CKD knowledge exchange to ensure early diagnosis and foster team-working, trust-building, and system resilience.

The outputs from this collaboration will be shared with participating stakeholders to develop a CKD action framework. This framework will highlight the need for transformation and improved efficiencies in care delivery through Health Innovation Manchester, localities, the Integrated Care System, and wider network partners.

 

NP-GB-104710     June 2024